LYB
NYSE · Chemicals
Lyondellbasell Indu-Cl A
$60.72
-0.91 (-1.48%)
Financial Highlights (FY 2026)
Revenue
30.72B
Net Income
-751,942,269
Gross Margin
8.5%
Profit Margin
-2.5%
Rev Growth
-15.8%
D/E Ratio
1.28
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 8.5% | 8.5% | 40.1% | 40.1% |
| Operating Margin | -1.4% | -1.3% | 11.7% | 12.6% |
| Profit Margin | -2.5% | -2.3% | 13.4% | 14.7% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 30.72B | 36.48B | 7.30B | 8.08B |
| Gross Profit | 2.63B | 3.12B | 2.92B | 3.24B |
| Operating Income | -433,194,367 | -462,869,441 | 854.25M | 1.02B |
| Net Income | -751,942,269 | -803,452,501 | 974.42M | 1.18B |
| Gross Margin | 8.5% | 8.5% | 40.1% | 40.1% |
| Operating Margin | -1.4% | -1.3% | 11.7% | 12.6% |
| Profit Margin | -2.5% | -2.3% | 13.4% | 14.7% |
| Rev Growth | -15.8% | -15.8% | +6.8% | +9.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 5.60B | 5.60B | 1.19B | 1.20B |
| Total Equity | 4.36B | 4.36B | 7.44B | 7.52B |
| D/E Ratio | 1.28 | 1.28 | 0.16 | 0.16 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 982.23M | 1.11B | 1.33B | 1.49B |
| Free Cash Flow | — | — | 1.05B | 1.41B |